Cited by 810Heart Failure Treatment and ManagementCardiac Fibrosis and RemodelingInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

Rauchhaus, Mathias, Doehner, Wolfram, Francis, Darrel P., Davos, Constantinos, Kemp, Michael, Liebenthal, Christa, Niebauer, Josef, Hooper, James, Volk, Hans-Dieter, Coats, Andrew J. S., Anker, Stefan D.·2000·Circulation

DOI 10.1161/01.cir.102.25.3060

Open this paper in CoChat — free account

Abstract

Background —Inflammatory immune activation is an important feature in chronic heart failure (CHF). Little is known about the prognostic importance of tumor necrosis factor-α (TNF-α), soluble TNF-receptor 1 and 2 (sTNF-R1/sTNF-R2), interleukin-6 (IL-6), and soluble CD14 receptors (sCD14) in CHF patients. Methods and Results —In 152 CHF patients (age 61±1 years, New York Heart Association [NYHA] class 2.6±0.1, peak V̇ o 2 17.3±0.6 mL · kg −1 · min −1 , mean±SEM) plasma concentrations of immune variables were prospectively assessed. During a mean follow-up of 34 months (>12 months in all patients), 62 patients (41%) died. Cumulative mortality was 28% at 24 months. In univariate analyses, increased total and trimeric TNF-α, sTNF-R1, and sTNF-R2 (all P ≤0.0001), sCD14 ( P =0.0007), and IL-6 ( P =0.005) predicted 24-month mortality. With multivariate analysis and receiver operating characteristics, sTNF-R1 emerged among all cytokine parameters as the strongest and most accurate prognosticator in this CHF population, regardless of follow-up duration and independently of NYHA class, peak V̇ o 2 , V̇ e /V̇ co 2 slope, left ventricular ejection fraction, and wasting ( P <0.001). The receiver operating characteristic area under the curve for sTNF-R1 was greater than for sTNF-R2 at 6, 12, and 18 months (all P <0.05). Conclusions —sTNF-R1 was the strongest and most accurate prognosticator, independent of established markers of CHF severity. Assessment of sTNF-R1 may be useful in identifying patients who are at high risk of death and in monitoring patients undergoing anti–TNF-α treatment.

Integrity signals

Registry

Crossref · 10.1161/01.cir.102.25.3060

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Wasting as independent risk factor for mortality in chronic heart failure
Anker, S. D., Ponikowski, P. P., Varney, S. J., Chua, T. P., Clark, A. L., Webb-Peploe, K., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399
Self-citation
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,147
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Torre‐Amione, G., Kapadia, S. R., Lee, J. J., Durand, J., Bies, R. D., Young, J. B., & Mann, D. L. (1996) · Circulation · doi:10.1161/01.cir.93.4.704 · Cited by 991
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
Self-citation
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Self-citation
Mechanisms and Models in Heart Failure
Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.100.9.999 · Cited by 769
Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction
Omland, T., Aakvaag, A., Bonarjee, V., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 698

Flagged first, then by citations

Show all 27 references

Research works printed but not linked: 7

10.1161/circ.96.2.526 · DOI
10.1161/circ.92.6.1479 · DOI
10.1161/circ.93.4.704 · DOI
10.1161/circ.82.5.2225374 · DOI
10.1161/circ.93.11.1963 · DOI
10.1161/circ.99.25.3224 · DOI
10.1161/circ.100.9.999 · DOI

Sorted by citations

Items 301–400 of 810

HMGB1 is an independent predictor of death and heart transplantation in heart failure
Volz, H. C., Laohachewin, D., Schellberg, D., Wienbrandt, A. R., Nelles, M., Zugck, C., Kaya, Z., Katus, H. A., & Andrassy, M. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0409-x · Cited by 44
Fractalkine is an independent predictor of mortality in patients with advanced heart failure
Koller, L., Hohensinner, P. J., Rychli, K., Zorn, G., Goliasch, G., Berger, R., Mörtl, D., Maurer, G., Huber, K., Pacher, R., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0195 · Cited by 46
Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles
Miyamoto, K., Takeuchi, D., Inai, K., Shinohara, T., & Nakanishi, T. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0807-0 · Cited by 44
Impact of physical exercise on alterations in the skeletal muscle in patients with chronic heart failure
Adams, V. (2007) · Frontiers in bioscience · doi:10.2741/2680 · Cited by 44
Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy
Christ, M., Klima, T. B., Grimm, W., Mueller, H., & Maisch, B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi195 · Cited by 44
Association between inflammation and skeletal muscle proteolysis, skeletal mass and strength in elderly heart failure patients and their prognostic implications
Koshikawa, M., Harada, M., Noyama, S., Kiyono, K., Motoike, Y., Nomura, Y., Nishimura, A., Izawa, H., Watanabe, E., & Ozaki, Y. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01514-0 · Cited by 43
Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo
Garlie, J. B., Hamid, T., Gu, Y., Ismahil, M. A., Chandrasekar, B., & Prabhu, S. D. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0196-6 · Cited by 43
Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease
Conraads, V. M., Beckers, P. J., Bosmans, J. M., Clerck, L. S. D., Stevens, W. J., Vrints, C. J., & Brutsaert, D. L. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(01)00568-x · Cited by 43
Serum but not myocardial TNF-α concentration is increased in pacing-induced heart failure in rabbits
Aker, S., Belosjorow, S., Konietzka, I., Duschin, A., Martin, C., Heusch, G., & Schulz, R. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00153.2003 · Cited by 45
Expression of immunological molecules by cardiomyocytes and inflammatory and interstitial cells in rat autoimmune myocarditis
Yoshida, T., Hanawa, H., TOBA, K., Watanabe, H., Watanabe, R., YOSHIDA, K., Abe, S., Kato, K., Kodama, M., & Aizawa, Y. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.006 · Cited by 41
The Effect of Oral Consumption of Probiotics in Prevention of Heart Injury in a Rat Myocardial Infarction Model: a Histopathological, Hemodynamic and Biochemical Evaluation
Sadeghzadeh, J., Vakili, A., Sameni, H. R., Shadnoush, M., Bandegi, A., & Khorasani, M. Z. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.3.174 · Cited by 42
Biologics and heart failure in rheumatoid arthritis: are we any wiser?
Danila, M. I., Patkar, N. M., Curtis, J. R., Saag, K. G., & Teng, G. G. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3282fb03d8 · Cited by 42
Rofecoxib, a COX-2 Inhibitor, Lowers C-Reactive Protein and Interleukin-6 Levels in Patients With Acute Coronary Syndromes
Monakier, D., Mates, M., Klutstein, M. W., Balkin, J., Rudensky, B., Meerkin, D., & Tzivoni, D. (2004) · CHEST Journal · doi:10.1378/chest.125.5.1610 · Cited by 42
Brain mechanisms of sympathetic activation in heart failure: Roles of the renin-angiotensin system, nitric oxide and pro-inflammatory cytokines (Review)
XU, B., & Li, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4434 · Cited by 41
The impact of obesity on heart failure
Zhai, A. B., & Haddad, H. A. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000370 · Cited by 41
The ‘aerobic/resistance/inspiratory muscle training hypothesis in heart failure’
Laoutaris, I. D. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318776097 · Cited by 42
Central sleep apnea and atrial fibrillation: A review on pathophysiological mechanisms and therapeutic implications
Sanchez, A. M., Germany, R. E., Lozier, M. R., Schweitzer, M. D., Kosseifi, S. G., & Anand, R. G. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100527 · Cited by 42
Attenuation of the LPS-induced, ERK-mediated upregulation of fibrosis-related factors FGF-2, uPA, MMP-2, and MMP-9 by Carthamus tinctorius L in cardiomyoblasts
Han, C.-K., Tien, Y.-C., Hsieh, D. J., Ho, T., Lai, C., Yeh, Y., Day, C. H., Shen, C.-Y., Hsu, H.-H., Lin, J.-Y., et al. (2016) · Environmental Toxicology · doi:10.1002/tox.22275 · Cited by 42
Immune cell β2-adrenergic receptors contribute to the development of heart failure
Tanner, M. A., Maitz, C. A., & Grisanti, L. A. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00243.2021 · Cited by 40
Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis
Hu, S., Yang, M., Huang, S., Zhong, S.-J., Zhang, Q., Ding, H., Xiong, X., Hu, S., & Yang, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.818188 · Cited by 41
A 21st century evaluation of the safety of oral vitamin D
Glade, M. J. (2012) · Nutrition · doi:10.1016/j.nut.2011.11.006 · Cited by 40
Cardio‐renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle
Cicoira, M., Anker, S. D., & Ronco, C. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0038-2 · Cited by 40
Self-citation
The impact of CD4+CD28null T-lymphocytes on atrial fibrillation and mortality in patients with chronic heart failure
Sulzgruber, P., Koller, L., Winter, M., Richter, B., Blum, S., Korpak, M., Hülsmann, M., Goliasch, G., Wojta, J., & Niessner, A. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-07-0531 · Cited by 40
Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients.
Haugen, E., Gan, L., Isic, A., Skommevik, T., & Fu, M. L. X. (2008) · PubMed Central · Cited by 40
Longitudinal Assessment of Inflammation in Recipients of Continuous-Flow Left Ventricular Assist Devices
Grosman‐Rimon, L., Jacobs, I. A., Tumiati, L. C., McDonald, M. A., Bar-Ziv, S. P., Fuks, A., Kawajiri, H., Lazarte, J., Ghashghai, A., Shogilev, D. J., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.12.006 · Cited by 39
HIF Activation Against CVD in CKD: Novel Treatment Opportunities
Tanaka, T., & Eckardt, K. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.02.006 · Cited by 40
Hypothalamic inflammation and food intake regulation during chronic illness
Dwarkasing, J. T., Marks, D. L., Witkamp, R. F., & van Norren, K. (2015) · Peptides · doi:10.1016/j.peptides.2015.06.011 · Cited by 41
Treatment of Fabry Disease: Established and Emerging Therapies
Umer, M., & Kalra, D. K. (2023) · Pharmaceuticals · doi:10.3390/ph16020320 · Cited by 38
Animal models of cardiorenal syndrome: a review
Szymanski, M. K., de Boer, R. A., Navis, G. J., van Gilst, W. H., & Hillege, H. L. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9279-6 · Cited by 38
TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
Ueland, T., Yndestad, A., Dahl, C. P., Gullestad, L. L., & Aukrust, P. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0088-6 · Cited by 37
Inflammation and Prolonged QT Time: Results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) Study
Medenwald, D., Kors, J. A., Loppnow, H., Thiery, J., Kluttig, A., Nuding, S., Tiller, D., Greiser, K. H., Werdan, K., & Haerting, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095994 · Cited by 37
Vitamin D deficiency and clinical outcome in patients with chronic heart failure: A review
D’Amore, C., Marsico, F., Parente, A., Paolillo, S., Martino, F. D., Gargiulo, P., Ferrazzano, F., Roberto, A. M. D., Mura, L. L., Marciano, C., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.07.009 · Cited by 38
Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis
Błyszczuk, P., & Szekanecz, Z. (2020) · RMD Open · doi:10.1136/rmdopen-2019-001032 · Cited by 38
Immune and Neurohormonal Pathways in Chronic Heart Failure
Sharma, R. K., & Anker, S. D. (2002) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00724.x · Cited by 37
Self-citation
Long Pentraxin PTX3 Exacerbates Pressure Overload–Induced Left Ventricular Dysfunction
Suzuki, S., Shishido, T., Funayama, A., Netsu, S., Ishino, M., Kitahara, T., Sasaki, T., Katoh, S., Otaki, Y., Watanabe, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053133 · Cited by 37
Heart Failure as an Inflammatory Condition: Potential Role for Androgens as Immune Modulators
Pugh, P. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00162-9 · Cited by 36
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure
Zoccali, C., Benedetto, F., Mallamaci, F., Tripepi, G. L., Cutrupi, S., Parlongo, S., Malatino, L., Bonanno, G. R., Rapisarda, F., Fatuzzo, P. M., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01169.x · Cited by 36
Intracellular Monocyte Cytokine Production and CD14 Expression Are Up-Regulated in Severe vs Mild Chronic Heart Failure
Conraads, V. M., Bosmans, J. M., Schuerwegh, A. J., Goovaerts, I., Clerck, L. S. D., Stevens, W. J., Bridts, C. H., & Vrints, C. J. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2004.04.017 · Cited by 36
Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium
Schillinger, W. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3044 · Cited by 36
Safety of Etanercept in Psoriasis
Carazo, J. L. S., Santos, L. M., & Martínez, V. O. (2006) · Drug Safety · doi:10.2165/00002018-200629080-00004 · Cited by 36
Endothelial progenitor cells in cardiovascular disease and hypoxia—potential implications to obstructive sleep apnea
Berger, S., & Lavie, L. (2011) · Translational research · doi:10.1016/j.trsl.2010.12.008 · Cited by 35
A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach
Strober, B. E., Berger, E., Cather, J. C., Cohen, D., Crowley, J., Gordon, K. B., Gottlieb, A. B., Horn, E. J., Kavanaugh, A. F., Korman, N. J., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.017 · Cited by 35
Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction
Bunsawat, K., Ratchford, S. M., Alpenglow, J. K., Park, S. H., Jarrett, C. L., Stehlik, J., Smith, A. S., Richardson, R. S., & Wray, D. W. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00454.2020 · Cited by 35
Predictors of Interleukin‐6 Elevation in Older Adults
Zhu, S., Patel, K. V., Bandinelli, S., Ferrucci, L., & Guralnik, J. M. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02426.x · Cited by 35
Transition from compensated hypertrophy to systolic heart failure in the spontaneously hypertensive rat: Structure, function, and transcript analysis
Brooks, W. W., Shen, S. S., Conrad, C. H., Goldstein, R. H., & Bing, O. H. L. (2009) · Genomics · doi:10.1016/j.ygeno.2009.12.002 · Cited by 35
Anemia and Cardiovascular Risk in the Patient with Kidney Disease
Fishbane, S. (2008) · Heart Failure Clinics · doi:10.1016/j.hfc.2008.03.005 · Cited by 35
Complement activation in diabetic ketoacidosis and its treatment
Jerath, R. S., Burek, C. L., Hoffman, W. H., & Passmore, G. G. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.03.004 · Cited by 35
Atrial natriuretic peptide and related peptides
Akashi, Y. J., Springer, J., Lainščak, M., & Anker, S. D. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.274 · Cited by 34
Self-citation
Atrial fibrillation is associated with increased neurohumoral activation and reduced exercise tolerance in patients with non-ischemic dilated cardiomyopathy
Parthenakis, F. I., Patrianakos, A. P., Skalidis, E. I., Diakakis, G. F., Zacharis, E. A., CHLOUVERAKIS, G. I., Karalis, I. K., & Vardas, P. E. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.090 · Cited by 33
Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy
Nakamura, T., Funayama, H., Kubo, N., Yasu, T., Kawakami, M., Momomura, S., & Ishikawa, S. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.050 · Cited by 34
Future prospects of anticytokine therapy in chronic heart failure
von Haehling, S., & Anker, S. D. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.163 · Cited by 34
Self-citation
sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy
Noutsias, M., Hohmann, C., Pauschinger, M., Schwimmbeck, P. L., Ostermann, K., Rode, U., Yacoub, M. H., Kühl, U., & Schultheiß, H. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(03)00033-0 · Cited by 34
Proinflammatory Cytokines Are Soluble Mediators Linked with Ventricular Arrhythmias and Contractile Dysfunction in a Rat Model of Metabolic Syndrome
Fernández-Sada, E., Torres‐Quintanilla, A., Silva‐Platas, C., Garcı́a, N., Willis, B. C., Rodríguez-Rodríguez, C., de la Peña-Almaguer, E., Bernal‐Ramírez, J., Treviño‐Saldaña, N., Oropeza‐Almazán, Y., et al. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7682569 · Cited by 33
High brain natriuretic peptide is associated with sarcopenia in patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study
Okamura, T., Hashimoto, Y., Miki, A., Kaji, A., Sakai, R., Iwai, K., Osaka, T., Kitagawa, N., Ushigome, E., Hamaguchi, M., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0024 · Cited by 34
Cerebral derailment after myocardial infarct: mechanisms and effects of the signaling from the ischemic heart to brain
Gelosa, P., Castiglioni, L., Rzemieniec, J., Muluhie, M., Camera, M., & Sironi, L. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02154-3 · Cited by 34
The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure
Wykrętowicz, A., Furmaniuk, J., Śmielecki, J., Deskur-Śmielecka, E., Szczepanik, A., Banaszak, A., & Wysocki, H. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.06.001 · Cited by 33
Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure
Chaugai, S., Tan, L., Huang, J., Li, Q., Ni, L., Cianflone, K., & Wang, D. W. (2016) · Medicine · doi:10.1097/md.0000000000004105 · Cited by 32
TNF‐α Inhibitors and Congestive Heart Failure
Behnam, S. M., Behnam, S. E., & Koo John, Y. (2005) · SKINmed Dermatology for the Clinician · doi:10.1111/j.1540-9740.2005.04502.x · Cited by 33
Inflammation in Heart Failure—Future Perspectives
Arvunescu, A. M., Ionescu, R. F., Creţoiu, S. M., Dumitrescu, S. I., Zaharia, O., & Nanea, I. T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247738 · Cited by 38
Biomarkers in Heart Failure
Takeishi, Y. (2014) · International Heart Journal · doi:10.1536/ihj.14-267 · Cited by 32
Type D personality and course of health status over 18 months in outpatients with heart failure: Multiple mediating inflammatory biomarkers
Mommersteeg, P. M. C., Pelle, A. J. M., Ramakers, C. R. B., Szabó, B. M., Denollet, J., & Kupper, N. H. M. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.09.010 · Cited by 32
Cachexia in heart disease: highlights from the ESC 2010
Kung, T., Szabo, T. S., Springer, J., Doehner, W., Anker, S. D., & von Haehling, S. (2011) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-011-0020-z · Cited by 32
Self-citation
Effects of β-Blocker Therapy on High Sensitivity C-Reactive Protein, Oxidative Stress, and Cardiac Function in Patients With Congestive Heart Failure
Nagatomo, Y., Yoshikawa, T., Kohno, T., Yoshizawa, A., Anzai, T., Meguro, T., Satoh, T., & Ogawa, S. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.02.004 · Cited by 32
N-Terminal Brain Natriuretic Peptide is a More Powerful Predictor of Mortality than Endothelin-1, Adrenomedullin and Tumour Necrosis Factor-α in Patients Referred for Consideration of Cardiac Transplantation
Gardner, R. S., Chong, V., Morton, I., & McDonagh, T. A. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.06.002 · Cited by 32
A Comprehensive Review: Unraveling the Role of Inflammation in the Etiology of Heart Failure
Pepine, D., Șerban, A. M., Capraș, R.-D., Cismaru, C. M., & Filip, G. A. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10519-w · Cited by 36
The Role of Procalcitonin in Acute Heart Failure Patients
Möckel, M. M., Searle, J., & Maisel, A. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12189 · Cited by 31
Neurohormones, inflammatory mediators, and cardiovascular injury in the setting of heart failure
Grosman‐Rimon, L., Billia, F., Wright, E., Carasso, S., Elbaz‐Greener, G., Kachel, E., Rao, V. A., & Cherney, D. Z. I. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09860-8 · Cited by 32
Cardiorenal Syndrome: An Updated Classification Based on Clinical Hallmarks
Pliquett, R. U. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102896 · Cited by 31
Cytokines and Matrix Metalloproteinases as Potential Biomarkers in Chronic Heart Failure
Deardorff, R. L., & Spinale, F. G. (2009) · Biomarkers in Medicine · doi:10.2217/bmm.09.60 · Cited by 31
Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction
Feldman, A. M., Mann, D. L., She, L., Bristow, M. R., Maisel, A. S., McNamara, D. M., Walsh, R., Lee, D. L., Woś, S., Lang, I. M., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000185 · Cited by 31
Anemia and heart failure
O’Meara, E., Murphy, C., & McMurray, J. J. V. (2004) · Current Heart Failure Reports · doi:10.1007/s11897-004-0006-7 · Cited by 30
Biologic Effects and Basic Science of a Novel Immune-Modulation Therapy
Bolton, A. E. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.009 · Cited by 31
Nutrition intervention to decrease symptoms in patients with advanced heart failure
Lennie, T. A., Moser, D. K., Biddle, M., Welsh, D., Bruckner, G. G., Thomas, D. T., Rayens, M. K., & Bailey, A. L. (2013) · Research in Nursing & Health · doi:10.1002/nur.21524 · Cited by 30
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
Palazzuoli, A., Ruocco, G. M., Pellegrini, M., Gori, C. D., Castillo, G. D., Nuti, R., & Giordano, N. G. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s61551 · Cited by 31
Inflammatory Biomarkers are not Predictive of Intermediate‐term Risk of Ventricular Tachyarrhythmias in Stable CHF Patients
Konstantino, Y., Kusniec, J., Reshef, T., David‐Zadeh, O., Mazur, A., Strasberg, B., Battler, A., & Haim, M. (2007) · Clinical Cardiology · doi:10.1002/clc.20110 · Cited by 30
Vitamin D and Vascular Disease
Gouni‐Berthold, I., & Berthold, H. K. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200317151955 · Cited by 31
Role of intestinal function in cachexia
Pirlich, M., Norman, K., Lochs, H. H., & Bauditz, J. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241671.09676.d8 · Cited by 29
Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos
Lee, C. J. M., Kosyakovsky, L. B., Khan, M. S., Wu, F., Chen, G., Hill, J. A., Ho, J. E., Foo, R., & Zannad, F. M. (2025) · Circulation Research · doi:10.1161/circresaha.125.325602 · Cited by 33
Clinical Adoption of Prognostic Biomarkers: The Case for Heart Failure
Kalogeropoulos, A. P., Georgiopoulou, V. V., & Butler, J. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.05.004 · Cited by 29
Effect of Aerobic Exercise on Treg and Th17 of Rats with Ischemic Cardiomyopathy
Chen, Z., Yan, W., Mao, Y., Ni, Y., Zhou, L., Song, H., Xu, W., Wang, L., & Shen, Y. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9794-0 · Cited by 29
Revisiting skeletal myopathy and exercise training in heart failure: Emerging role of myokines
Ramírez‐Vélez, R., González, A., García‐Hermoso, A., Latasa, I., Izquierdo, M., & Dı́ez, J. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155348 · Cited by 32
Increased serum HMGB1 level may predict the fatal outcomes in patients with chronic heart failure
Liu, T., Zhang, D.-Y., Zhou, Y., Han, Q.-F., Wang, L., Wu, L., & Yao, H.-C. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.02.088 · Cited by 28
An overview of human pericardial space and pericardial fluid
Hassanabad, A. F., Zarzycki, A. N., Deniset, J., & Fedak, P. W. M. (2021) · Cardiovascular Pathology · doi:10.1016/j.carpath.2021.107346 · Cited by 28
Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic Patients
Bin-Jumah, M. N., Gilani, S. J., Hosawi, S. B. I., Al-Abbasi, F. A., Zeyadi, M., Imam, S. S., Alshehri, S., Ghoneim, M. M., Nadeem, M. S., & Kazmi, I. A. (2021) · Nutrients · doi:10.3390/nu13103453 · Cited by 28
New Insights Into the Role of Inflammation in the Brain in Heart Failure
Badoer, E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.837723 · Cited by 28
Soluble Tumor Necrosis Factor Receptor 1 Level Is Associated With Left Ventricular Hypertrophy: The Northern Manhattan Study
Takei, Y., Tullio, M. R. D., Homma, S., Boden-Albala, B. M., Rundek, T., Sacco, R. L., Berry, G., Liu, R., Jin, Z., Eguchi, K., et al. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.79 · Cited by 28
Chronic Inflammatory Cardiomyopathy of Interferon γ–Overexpressing Transgenic Mice Is Mediated by Tumor Necrosis Factor-α
Torzewski, M., Wenzel, P., Kleinert, H., Becker, C., El-Masri, J., Wiese, E., Brandt, M., Pautz, A., Twardowski, L., Schmitt, E., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.006 · Cited by 28
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review
Doehner, W., von Haehling, S., Anker, S. D., & Lainščak, M. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1194-7 · Cited by 28
Self-citation
Anemia in Chronic Heart Failure
Drakos, S. G., ANASTASIOU‐NANA, M. I., Malliaras, K. G., & Nanas, J. N. (2009) · Congestive Heart Failure · doi:10.1111/j.1751-7133.2009.00049.x · Cited by 28
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure
de Virginy, D. R. B. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-0234-x · Cited by 28
C-Reactive Protein Is Elevated in Heart Failure Patients with Central Sleep Apnea and Cheyne-Stokes Respiration
Schmalgemeier, H., Bitter, T., Fischbach, T. J., Horstkotte, D., & Oldenburg, O. (2013) · Respiration · doi:10.1159/000351115 · Cited by 29
Multiple cytokine biomarkers in heart failure
Vistnes, M., Christensen, G., & Omland, T. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.3 · Cited by 27
ERK1/2 mediates the lipopolysaccharide-induced upregulation of FGF-2, uPA, MMP-2, MMP-9 and cellular migration in cardiac fibroblasts
Chen, L.-C., Shibu, M. A., Liu, C., Han, C., Ju, D., Chen, P., Viswanadha, V. P., Lai, C.-H., Kuo, W., & Huang, C. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.010 · Cited by 27
Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults
Al-Kindi, S. G., Bůžková, P., Shitole, S. G., Reiner, A. P., Garg, P. K., Gottdiener, J. S., Psaty, B. M., & Kizer, J. R. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.03.003 · Cited by 27
Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuria
Miyazawa, I., Araki, S., Obata, T., Yoshizaki, T., Morino, K., Kadota, A., Ugi, S., Kawai, H., Uzu, T., Nishio, Y., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.01.008 · Cited by 27
Inflammation and future risk of symptomatic heart failure in patients with stable coronary artery disease
Eisen, A., Benderly, M., Behar, S., Goldbourt, U., & Haim, M. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.01.008 · Cited by 27
Depression in heart failure
Moudgil, R., & Haddad, M. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32835ced80 · Cited by 29
Soluble TNF and IL-6 receptors: Indicators of vascular health in women without cardiovascular disease
Cortez‐Cooper, M. Y., Meaders, E., Stallings, J., Haddow, S., Kraj, B., Sloan, G. J., McCully, K. K., & Cannon, J. G. (2013) · Vascular Medicine · doi:10.1177/1358863x13508336 · Cited by 27
Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II
Ufnal, M., Dudek, M., Żera, T., & Szczepanska‐Sadowska, E. K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.122 · Cited by 27
Chronic Heart Failure and the Immune System
Mari, D., Berardino, F. D., & Cugno, M. (2002) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:23:3:325 · Cited by 27

Authors: Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., & Anker, S. D.
Affiliations: Royal Brompton Hospital (GB)
From Clinical Cardiology, National Heart and Lung Institute (M.R., W.D., D.P.F., C.D., J.N., A.J.S.C., S.D.A.), and Biochemistry, Royal Brompton Hospital (M.K., J.H.), London, UK; the Universitätsklinik und Poliklinik für Innere Medizin III, Martin-Luther-Universität (M.R.), Halle, Germany; and the Institut für Medizinische Immunologie, Charité (Campus Mitte) (C.L., H.-D.V.), and Franz-Volhard-Klinik (Charité, Campus Berlin-Buch) am Max-Delbrück Centrum für Molekulare Medizin (S.D.A.),...
ORCID: Doehner, Wolfram
Davos, Constantinos
Niebauer, Josef
Hooper, James
Volk, Hans-Dieter
Coats, Andrew J. S.
Anker, Stefan D.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-12-19
Volume: 102
Issue: 25
Pages: 3060-3067
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.102.25.3060
OpenAlex: W2066885413
Cited by: 810
References: 27
Citations by year: 2026: 15 · 2025: 19 · 2024: 25 · 2023: 20 · 2022: 31 · 2021: 24 · 2020: 31 · 2019: 22 · 2018: 26 · 2017: 24 · 2016: 24 · 2015: 24 · 2014: 35 · 2013: 35 · 2012: 35
FWCI: 21.26
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords: chronic heart failure, plasma cytokines, soluble TNF receptor 1, soluble TNF receptor 2, TNF-α, interleukin-6, soluble CD14, inflammation, mortality prediction, prognostic factors, anti-TNF therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Analysis of Variance, Cardiac Output, Low, Chronic Disease, Female, Humans, Immunoassay, Male, Middle Aged, Prognosis, ROC Curve, Solubility, Tumor Necrosis Factor-alpha, Biomarkers, Antigens, CD, Interleukin-6, Survival Analysis, Cytokines, Receptors, Tumor Necrosis Factor, Lipopolysaccharide Receptors, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks